These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 21367693)

  • 1. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy.
    Cao DJ; Wang ZV; Battiprolu PK; Jiang N; Morales CR; Kong Y; Rothermel BA; Gillette TG; Hill JA
    Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4123-8. PubMed ID: 21367693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
    Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
    J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
    Zhao Z; Lv J; Guo N; Guo Q; Zeng S; Fang Y; Chen W; Wang Z
    Curr Drug Targets; 2023; 24(4):371-378. PubMed ID: 36734909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy.
    Kee HJ; Kook H
    J Mol Cell Cardiol; 2009 Dec; 47(6):770-80. PubMed ID: 19729022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
    Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
    Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
    Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
    Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts.
    Wang Y; Chen P; Wang L; Zhao J; Zhong Z; Wang Y; Xu J
    Cell Physiol Biochem; 2018; 49(5):1999-2011. PubMed ID: 30235443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel histone deacetylase inhibitor Se-SAHA attenuates isoproterenol-induced heart failure via antioxidative stress and autophagy inhibition.
    Cheng T; Liu C; Wang Y; Li G; Feng L; Zhang S; Qi B; Cui J; Guo L; Cao L; Wang Y; Qi Z; Yang L
    Toxicol Appl Pharmacol; 2024 Jun; 487():116957. PubMed ID: 38735590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
    Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H
    Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.
    Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
    Raghunathan S; Goyal RK; Patel BM
    Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
    Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
    Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes.
    Blakeslee WW; Lin YH; Stratton MS; Tatman PD; Hu T; Ferguson BS; McKinsey TA
    J Mol Cell Cardiol; 2017 Nov; 112():74-82. PubMed ID: 28886967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
    Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
    Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors.
    Antos CL; McKinsey TA; Dreitz M; Hollingsworth LM; Zhang CL; Schreiber K; Rindt H; Gorczynski RJ; Olson EN
    J Biol Chem; 2003 Aug; 278(31):28930-7. PubMed ID: 12761226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate ameliorates the cardiac hypertrophic response through inhibiting the activity of histone deacetylase-2.
    Yan H; Yi S; Zhuang H; Wu L; Wang DW; Jiang J
    Int J Mol Med; 2018 Mar; 41(3):1704-1714. PubMed ID: 29286094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
    Renaud L; Harris LG; Mani SK; Kasiganesan H; Chou JC; Baicu CF; Van Laer A; Akerman AW; Stroud RE; Jones JA; Zile MR; Menick DR
    Circ Heart Fail; 2015 Nov; 8(6):1094-104. PubMed ID: 26371176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.
    Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF
    Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
    Kee HJ; Kook H
    J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.